Evanson Asset Management’s Evolent Health EVH Stock Holding History

Evanson Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$72K	–	237
2019 Q3	$72K	Hold	10,000	–	–	0.01%	232
2019 Q2	$80K	Hold	10,000	–	–	0.02%	236
2019 Q1	$126K	Hold	10,000	–	–	0.03%	233
2018 Q4	$200K	Hold	10,000	–	–	0.05%	213
2018 Q3	$284K	Hold	10,000	–	–	0.06%	193
2018 Q2	$211K	Sell	10,000 -1,000	-9%	-$18.9K	0.04%	234
2018 Q1	$157K	Hold	11,000	–	–	0.03%	241
2017 Q4	$135K	Hold	11,000	–	–	0.03%	239
2017 Q3	$196K	Hold	11,000	–	–	0.04%	219
2017 Q2	$279K	Hold	11,000	–	–	0.06%	178
2017 Q1	$245K	Hold	11,000	–	–	0.06%	184
2016 Q4	$163K	Buy	11,000 +1,000	+10%	+$19.7K	0.05%	207
2016 Q3	$246K	Hold	10,000	–	–	0.07%	172
2016 Q2	$192K	Hold	10,000	–	–	0.06%	187
2016 Q1	$106K	Buy	+10,000	New	+$103K	0.04%	191

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Evanson Asset Management's EVH Position: Q4 2019 in Review

Evanson Asset Management sold out of Evolent Health (EVH) in Q4 2019, closing a stake of 10,000 shares — an estimated $72K sold.

Evanson Asset Management first reported a position in EVH in Q1 2016 and held it in 15 quarters. The position peaked at $284K in Q3 2018. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

Evanson Asset Management reported no remaining Evolent Health position as of Q4 2019 after selling out during the quarter.
Evanson Asset Management sold 10,000 Evolent Health shares in Q4 2019, an estimated $72K.
Evanson Asset Management first reported a position in Evolent Health in Q1 2016 and held it in 15 quarters.
Evanson Asset Management's Evolent Health position peaked at $284K in Q3 2018.
167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Evanson Asset Management's 13F filing for Q4 2019, filed 13 Jan 2020.